Episode Synopsis "Barriers to insulin: Management in type 2 diabetes patients (with Lori Berard)"

Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on August 1, 2018.

Listen "Barriers to insulin: Management in type 2 diabetes patients (with Lori Berard)"

More episodes of the podcast Medicine Matters diabetes

• Why psychosocial care matters: Supporting people with diabetes in the pandemic (with Michael Vallis)
• World Diabetes Day 2020: Why nurses make the difference (with Lori Berard and Sharon Tovey)
• EASD 2020: Highlights from the Editorial Board (with Sanjay Kalra, John Wilding and Lori Berard)
• Why psychosocial care matters: Disengagement with diabetes (with Bill Polonsky)
• Why psychosocial care matters: Optimal medication taking in diabetes (with Kirsty Winkley)
• Why psychosocial care matters: Working with people using diabetes technology (with Thomas Kubiak)
• Why psychosocial care matters: The psychological impact of hypoglycemia (with Christel Hendrieckx)
• Why psychosocial care matters: Diabetes distress (with William Polonsky)
• Why psychosocial care matters: The role of the PSAD (with Frank Snoek)
• The DiRECT approach to weight loss: Efficacious and pragmatic (with Alison Barnes)
• ADA 2020 Goes Virtual! Editorial Board conference highlights (with Lori Berard, John Wilding, & Sanjay Kalra
• Closed-loop insulin delivery research update from ADA 2020 (with Rayhan Lal)
• Is oral semaglutide a game changer or nice-to-have for type 2 diabetes? (with Neil Skolnik)
• Alison Evert on the ADA consensus report on nutrition therapy for adults with diabetes or prediabetes
• Peer mentoring for teens with type 1 diabetes (with Ashby Walker)
• How was it for you? The experts discuss EASD 2019 (with John Wilding, Sanjay Kalra, and Lori Berard)
• REWIND, DECLARE, and high-risk diabetes patients (with Kamlesh Khunti)
• Nephrologist expert commentary: The CREDENCE trial (with Andrew Frankel)
• Barriers to insulin: Management in type 2 diabetes patients (with Lori Berard)
• UK nutrition guidelines: A fresh approach (with John Wilding and Pamela Dyson)
• SGLT2 inhibitors: The story so far (with John Wilding)
• Dissecting the CANVAS trial (with Carol Wysham and Lori Berard)
• Primary care expert commentary: The CREDENCE trial (with Kevin Fernando)
• Researcher comment: The CREDENCE trial (with Vlado Perkovic)
• Barriers to insulin: Initiation in type 2 diabetes patients (with Lori Berard)